Sab Biotherapeutics, Inc. · NASDAQ:SABS

BVF PARTNERS L P/IL reported a 9.10% stake in Sab Biotherapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

BVF PARTNERS L P/IL reported a 9.10% stake in Sab Biotherapeutics, Inc., 4,761,906 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
9.10%
Shares
4,761,906
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P5.10%2,540,159
BVF I GP LLC5.10%2,540,159
BIOTECHNOLOGY VALUE FUND II LP3.90%1,931,905
BVF II GP LLC3.90%1,931,905
Biotechnology Value Trading Fund OS LP0.50%225,556
BVF Partners OS Ltd.0.50%225,556
BVF GP HOLDINGS LLC8.60%4,472,064
BVF PARTNERS L P/IL9.10%4,761,906
BVF INC/IL9.10%4,761,906
LAMPERT MARK N9.10%4,761,906

Source

View original at SEC

Related